Transient Suppression of Dopamine Transporter Palmitoylation by Methamphetamine: Implications for Transport Regulation.
Hovde. Moriah J MJ; Bolland. Danielle E DE; Kleinsasser. Corey D CD; Shetty. Madhur M; Blackwell. Aaron C AC; Golovko. Mikhail Y MY; Golovko. Svetlana A SA; Brown. Christopher R CR; Foster. James D JD; Vaughan. Roxanne A RA
Key Findings
- Methamphetamine causes a rapid, temporary drop in dopamine transporter palmitoylation in rat brain tissue and cell models.
- Reduced palmitoylation is linked to decreased dopamine reuptake activity, and a transporter lacking this modification is even more sensitive to methamphetamine.
- Palmitoylation levels bounce back faster than dopamine transport function, indicating other down‑regulation processes stay active after repalmitoylation.
Practical Outcomes
- For most biohackers, the findings don’t translate into a direct, usable protocol. It mainly adds mechanistic insight into how methamphetamine affects dopamine signaling, which may be of interest for those studying drug effects or dopamine‑related performance enhancers, but it offers no actionable steps for supplementation or lifestyle changes.
Summary
The study shows that methamphetamine quickly reduces a lipid modification (palmitoylation) on the dopamine transporter, which temporarily slows dopamine reuptake. This effect is reversible, but the transporter’s function recovers more slowly than the palmitoylation itself, suggesting a complex regulation mechanism.
Abstract
The dopamine transporter (DAT) exerts temporal and spatial control over dopaminergic neurotransmission through reuptake of extracellular dopamine (DA). The functional capacity of DAT is under the control of signaling inputs and post-translational modifications that confer acute presynaptic regulation of reuptake in response to physiological needs, and dysregulation of these processes may contribute to DA imbalances in mood disorders and drug addiction. A key modification of DAT is palmitoylation, a lipid adduction that enhances transport velocity, is suppressed by protein kinase C, and opposes protein kinase C-mediated down-regulation. Here we now show in rat striatum and heterologous cells that transporter palmitoylation is also linked to methamphetamine (METH), undergoing rapid and transient reductions in response to the drug. The time course and other characteristics of palmitoylation reduction parallel those of METH-induced transport down-regulation, and a palmitoylation-deficient DAT mutant shows enhanced down-regulation to METH, supporting a mechanistic link between reduction of the modification and reduced reuptake activity. Recovery rates differed, however, with palmitoylation returning to starting levels more rapidly than reuptake, indicating that down-regulation mechanisms remain engaged with transporters that have undergone repalmitoylation. These results support palmitoylation as a rapid response mechanism that modulates the entry of DAT into METH-induced down-regulation states and suggest a broader role for the modification in control of reuptake in additional physiological and pathophysiological conditions.
Study Information
pubmed
2025
2025-11-15T00:00:00.000Z
10.1096/fj.202501472r